Relationship of HLA antigens and cryoglobulinaemia in hepatitis C virus infected patients. 2007

Sabiha Anis, and Rana Muzaffar, and Mirza Naqi Zafar, and Ejaz Ahmed, and Kiran Fatima, and Syed Ali Anwar Naqvi, and Syed Adibul Hasan Rizvi
Department of Microbiology and Immunology,Sindh Institute of Urology and Transplantation, Karachi. Pakistan.

OBJECTIVE To find the relationship between human leukocyte antigens (HLA) and cryoglobulin positivity in hepatitis C virus (HCV) infected individuals. METHODS Eligible individuals selected from pre and post renal transplant settings were divided into three groups. Group A (n = 301) consisted of normal controls, while group B (n = 200) comprised of pathological controls that were HCV antibody (anti-HCV) positive but negative for cryoglobulins. Group C comprised of 56 anti-HCV positive, cryoglobulin positive patients. HLA-A, -B and -DRB1 loci were typed by polymerase chain reaction (PCR) method and relationship between HLA antigens, anti-HCV status and cryoglobulinaemia was analyzed. RESULTS HLA-A*02, -B*57 and -DRB1*03 were more frequently found among group C members as compared to groups A and B. Only HLA-B* 57 occurrence reached statistical significance (14.3% versus 6% and 4%, corrected P-value = 0.045 and 0.012 and OR = 2.6 and 4 respectively) No differences in the distribution of HLA antigens were seen among healthy and pathological controls. CONCLUSIONS The presence of HLA-B*57 confers susceptibility to cryoglobulinaemia in HCV infected patients in our population. HCV positive renal transplant recipients with these alleles should be monitored for cryoglobulin formation).

UI MeSH Term Description Entries
D008297 Male Males
D003449 Cryoglobulinemia A condition characterized by the presence of abnormal quantities of CRYOGLOBULINS in the blood. Upon cold exposure, these abnormal proteins precipitate into the microvasculature leading to restricted blood flow in the exposed areas. Cryoglobulinemias
D004198 Disease Susceptibility A constitution or condition of the body which makes the tissues react in special ways to certain extrinsic stimuli and thus tends to make the individual more than usually susceptible to certain diseases. Diathesis,Susceptibility, Disease,Diatheses,Disease Susceptibilities,Susceptibilities, Disease
D005260 Female Females
D006526 Hepatitis C INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown. Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted,Parenterally-Transmitted Non-A, Non-B Hepatitis,PT-NANBH,Parenterally Transmitted Non A, Non B Hepatitis
D006680 HLA Antigens Antigens determined by leukocyte loci found on chromosome 6, the major histocompatibility loci in humans. They are polypeptides or glycoproteins found on most nucleated cells and platelets, determine tissue types for transplantation, and are associated with certain diseases. Human Leukocyte Antigen,Human Leukocyte Antigens,Leukocyte Antigens,HL-A Antigens,Antigen, Human Leukocyte,Antigens, HL-A,Antigens, HLA,Antigens, Human Leukocyte,Antigens, Leukocyte,HL A Antigens,Leukocyte Antigen, Human,Leukocyte Antigens, Human
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D016022 Case-Control Studies Comparisons that start with the identification of persons with the disease or outcome of interest and a control (comparison, referent) group without the disease or outcome of interest. The relationship of an attribute is examined by comparing both groups with regard to the frequency or levels of outcome over time. Case-Base Studies,Case-Comparison Studies,Case-Referent Studies,Matched Case-Control Studies,Nested Case-Control Studies,Case Control Studies,Case-Compeer Studies,Case-Referrent Studies,Case Base Studies,Case Comparison Studies,Case Control Study,Case Referent Studies,Case Referrent Studies,Case-Comparison Study,Case-Control Studies, Matched,Case-Control Studies, Nested,Case-Control Study,Case-Control Study, Matched,Case-Control Study, Nested,Case-Referent Study,Case-Referrent Study,Matched Case Control Studies,Matched Case-Control Study,Nested Case Control Studies,Nested Case-Control Study,Studies, Case Control,Studies, Case-Base,Studies, Case-Comparison,Studies, Case-Compeer,Studies, Case-Control,Studies, Case-Referent,Studies, Case-Referrent,Studies, Matched Case-Control,Studies, Nested Case-Control,Study, Case Control,Study, Case-Comparison,Study, Case-Control,Study, Case-Referent,Study, Case-Referrent,Study, Matched Case-Control,Study, Nested Case-Control
D016133 Polymerase Chain Reaction In vitro method for producing large amounts of specific DNA or RNA fragments of defined length and sequence from small amounts of short oligonucleotide flanking sequences (primers). The essential steps include thermal denaturation of the double-stranded target molecules, annealing of the primers to their complementary sequences, and extension of the annealed primers by enzymatic synthesis with DNA polymerase. The reaction is efficient, specific, and extremely sensitive. Uses for the reaction include disease diagnosis, detection of difficult-to-isolate pathogens, mutation analysis, genetic testing, DNA sequencing, and analyzing evolutionary relationships. Anchored PCR,Inverse PCR,Nested PCR,PCR,Anchored Polymerase Chain Reaction,Inverse Polymerase Chain Reaction,Nested Polymerase Chain Reaction,PCR, Anchored,PCR, Inverse,PCR, Nested,Polymerase Chain Reactions,Reaction, Polymerase Chain,Reactions, Polymerase Chain

Related Publications

Sabiha Anis, and Rana Muzaffar, and Mirza Naqi Zafar, and Ejaz Ahmed, and Kiran Fatima, and Syed Ali Anwar Naqvi, and Syed Adibul Hasan Rizvi
January 2000, Annals of the rheumatic diseases,
Sabiha Anis, and Rana Muzaffar, and Mirza Naqi Zafar, and Ejaz Ahmed, and Kiran Fatima, and Syed Ali Anwar Naqvi, and Syed Adibul Hasan Rizvi
April 1991, Lancet (London, England),
Sabiha Anis, and Rana Muzaffar, and Mirza Naqi Zafar, and Ejaz Ahmed, and Kiran Fatima, and Syed Ali Anwar Naqvi, and Syed Adibul Hasan Rizvi
March 1994, British journal of rheumatology,
Sabiha Anis, and Rana Muzaffar, and Mirza Naqi Zafar, and Ejaz Ahmed, and Kiran Fatima, and Syed Ali Anwar Naqvi, and Syed Adibul Hasan Rizvi
July 1993, European journal of clinical investigation,
Sabiha Anis, and Rana Muzaffar, and Mirza Naqi Zafar, and Ejaz Ahmed, and Kiran Fatima, and Syed Ali Anwar Naqvi, and Syed Adibul Hasan Rizvi
January 1998, Forum (Genoa, Italy),
Sabiha Anis, and Rana Muzaffar, and Mirza Naqi Zafar, and Ejaz Ahmed, and Kiran Fatima, and Syed Ali Anwar Naqvi, and Syed Adibul Hasan Rizvi
September 2009, Liver international : official journal of the International Association for the Study of the Liver,
Sabiha Anis, and Rana Muzaffar, and Mirza Naqi Zafar, and Ejaz Ahmed, and Kiran Fatima, and Syed Ali Anwar Naqvi, and Syed Adibul Hasan Rizvi
August 1998, Italian journal of gastroenterology and hepatology,
Sabiha Anis, and Rana Muzaffar, and Mirza Naqi Zafar, and Ejaz Ahmed, and Kiran Fatima, and Syed Ali Anwar Naqvi, and Syed Adibul Hasan Rizvi
July 1999, Gut,
Sabiha Anis, and Rana Muzaffar, and Mirza Naqi Zafar, and Ejaz Ahmed, and Kiran Fatima, and Syed Ali Anwar Naqvi, and Syed Adibul Hasan Rizvi
November 1997, European journal of gastroenterology & hepatology,
Sabiha Anis, and Rana Muzaffar, and Mirza Naqi Zafar, and Ejaz Ahmed, and Kiran Fatima, and Syed Ali Anwar Naqvi, and Syed Adibul Hasan Rizvi
August 1993, British journal of rheumatology,
Copied contents to your clipboard!